Seeking Alpha

Anoro Ellipta cleared in Japan

  • The Japanese Ministry of Health, Labor and Welfare approves GlaxoSmithKline (GSK) and Theravance's (THRX) Anoro Ellipta (umeclidinium/vilanterol) for the relief of various symptoms of chronic obstructive pulmonary diseases in patients who require the concurrent use of a long-acting inhaled muscarinic antagonist and a long-acting inhaled beta2 agonist.
  • Anoro is a once-daily treatment comprised of two broncodilators. Umeclidinium is the muscarinic antagonist and vilanterol is the beta2 agonist.
  • Under the terms of the companies' 2002 collaboration agreement, Theravance is obligated to pay Glaxo a milestone payment of $10M based on Japanese regulatory approval.
From other sites
Comments (3)
  • Cheriac
    , contributor
    Comments (13) | Send Message
    I own THRX and TBPH. What is the difference in the two companies. Can someone help me. This sounds like TBPH should be affected not THRX.


    4 Jul 2014, 11:29 PM Reply Like
  • John Vincent
    , contributor
    Comments (375) | Send Message
    Hi Cheriac,


    TBPH was spun out of THRX last month. TBPH is an early stage biotech that will have an 85% economic interest in the programs partnered with Glaxo that are still in research phase (Phase II and below drugs in the pipeline).


    THRX is now a royalty business that will get royalties from Glaxo for a couple of drugs that have blockbuster potential: RELVAR®/BREO® ELLIPTA® ("Relvar/Breo") and ANORO™ ELLIPTA™. There is also a third drug called Vibativ (FDA-approved injectible antibiotic to treat patients with hospital-acquired and ventilator associated bacterial pneumonia) and they will also have a 15% economic interest in TBPH's programs.


    Management have said that TBPH is similar to THRX of a few years ago. The business structure of new THRX is some what similar to PDLI and that is something you could look at.


    All the best,
    5 Jul 2014, 01:11 AM Reply Like
  • Cheriac
    , contributor
    Comments (13) | Send Message
    Thanks for the excellent explanation!
    5 Jul 2014, 02:27 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs